Margins
← 실적 발표
01
02
03
04 05 06
톤
자본지출
A1 A2 A3 A4
IFF
FY2026 Q1
예상 부합
International Flavors & Fragrances, Inc. 실적 발표
Buzzberg 분석
Q1 EBITDA margin highest since Q2 2022
IFF reported a strong Q1 2026 with better-than-expected volume growth and margin expansion, but management maintained full-year guidance, citing significant inflation and Middle East conflict-related headwinds expected to impact Q2 and the rest of the year. Strong Q1: Revenue of >$2.7B (+3% CC) and Adjusted EBITDA of $568M (+8% CC) beat internal expectations, driven by volume across all segments.
Buzzberg 분석 Q1 EBITDA margin highest since Q2 2022 IFF reported a strong Q1 2026 with better-than-expected volume growth and margin expansion, but management maintained full-year guidance, citing significant inflation and Middle East conflict-related headwinds expected to impact Q2 and the rest of the year. Strong Q1: Revenue of >$2.7B (+3% CC) and Adjusted EBITDA of $568M (+8% CC) beat internal expectations, driven by volume across all segments. 전체 분석 보기분석 접기
IFF reported a strong Q1 2026 with better-than-expected volume growth and margin expansion, but management maintained full-year guidance, citing significant inflation and Middle East conflict-related headwinds expected to impact Q2 and the rest of the year. Strong Q1: Revenue of >$2.7B (+3% CC) and Adjusted EBITDA of $568M (+8% CC) beat internal expectations, driven by volume across all segments.
- Full-year guidance maintained at $10.5B-$10.8B revenue and $2.05B-$2.15B EBITDA, despite a stronger Q1, due to a more cautious outlook for Q2.
- Q2 EBITDA expected to be lower than Q1 due to Middle East conflict impacting fine fragrance demand, inflation starting to hit, and pricing surcharges not yet fully implemented.
- Divestiture of commodity soy business to Bungie closed in March; sale process for food ingredients is advanced with an update expected by Q2 call.
매출$2.741B+6% 전분기 대비
주당순이익(EPS)$1.25+56% 전분기 대비
매출총이익률37.14%보고값
영업이익률10.18%보고값
근거 있는 핵심 내용 6개
지금 중요한 점
이번 발표에서 가장 의미 있는 변화를 정리했습니다.
Portfolio
Food ingredients divestiture progressing with multiple buyers
Guidance
Q2 EBITDA expected lower due to Middle East conflict
핵심 내용 3개 더 보기
Pricing
Pricing surcharges to offset inflation, but lag in Q2
Product Strategy
De-emphasizing commodity fragrance ingredients sales
Cash Flow
Working capital and cash flow improvement key focus
보고 기간
보고 실적
| 지표 | 보고값 | 변화 |
|---|---|---|
| 매출 | $2.741B | +6% 전분기 대비 |
| 주당순이익(EPS) | $1.25 | +56% 전분기 대비 |
| 매출총이익률 | 37.14% | 보고값 |
| 영업이익률 | 10.18% | 보고값 |
| 잉여현금흐름 | $0.092B | -29% 전분기 대비 |
| 자본지출 | $0.165B | 보고값 |
향후 전망
향후 가이던스
| 지표 | 기간 | 범위 | 중간값 | 상태 |
|---|---|---|---|---|
| 영업이익률 | FY2026 | $2.05B–$2.15B | $2.1B | 유지 |
| 매출 | FY2026 | $10.5B–$10.8B | $10.65B | 유지 |
AI, 자본지출 및 수요 분석
경영진 분석
Cautiously Optimisti
Management reaffirmed full-year guidance despite acknowledging ongoing macro uncertainty and Middle East conflict, expressing confidence in execution while highlighting challenges ahead.
투자 및 생산능력
Management mentioned opening a fermentation-based enzyme production site in Argentina and a household care application laboratory in Brazil to support health and biosciences growth in Latin America. CapEx was $165 million year-to-date, roughly 6% of sales.
아래에 언급된 기업 1개 모두 표시
기업발표 이후 수익률
공급망
ANDURIL
공급망
Eric Fehrwald
This is a low-confidence, periphery mention of Anduril based on a likely mis-transcription of 'Arellito' site; no substantive signal about the private company is provided.
근거
“In Q1, we also announced regional production and added innovation capabilities to better support the continued strong growth of our health and biosciences business in Latin America.”
외부 신호
공급망 알파 · 4발표 이후 수익률
Q2 2026 EBITDA is guided to be lower than the $568 million reported in Q1, driven by a temporary slowdown in Middle East fine fragrance volume and customer supply chain challenges (e.g., packaging)
근거
“We anticipate that fine fragrance volume in the Middle East will be impacted in the second quarter due to slower market demands, but also temporary supply chain challenges our customers are facing, such as getting packaging into the region.”
IFF is facing double-digit increases in energy and logistics costs immediately, before raw material inflation hits, prompting it to implement pricing surcharges with customers.
근거
“We're seeing energy and logistic charges rising, and we haven't really fully implemented our surcharges in place yet, and that will happen over the course of the quarter.”
IFF is explicitly de-emphasizing its 'commodity' fragrance ingredients business (roughly half of its ~$500M annual ingredient sales) due to intense price competition from Indian and Chinese producers.
근거
“On the commodity side, that's the part that's very, very challenged and challenged by Indian producers, Chinese producers, and it's an area that we need to continue to have competitive costs for our internal formulation use but we're de-em…”
IFF's food ingredients business sale process is advanced with multiple buyers in second-round due diligence; an update is expected by the Q2 earnings call.
근거
“We are running a very disciplined process and it's going very well with several potential buyers going through second round of due diligence and the feedback has been very positive so far.”
방법론 및 범위
경영진 발언만 분석합니다. 검증된 기업 언급 1개를 모두 표시하며, 보고 실적과 향후 가이던스를 분리합니다. 공개 근거는 화자가 표시된 짧은 인용문 8개로 제한됩니다. AI 분석은 불완전하거나 틀릴 수 있으므로 중요한 주장은 원문에서 확인하세요.